The prognostic factors in patients with advanced hepatocellular carcinoma: impact of treatment sequencing.

Autor: Köstek O; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Demirel A; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Hacıoğlu MB; Department of Medical Oncology, Trakya University, Istanbul, Turkiye., Tastekin D; Department of Medical Oncology, Istanbul University, Istanbul, Turkiye., Karabulut S; Department of Medical Oncology, Istanbul University, Istanbul, Turkiye., Gündogdu A; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Sever N; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Ayhan M; Clinic of Medical Oncology, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkiye., Çelebi A; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Majidova N; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Yaşar A; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Ağyol Y; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Erel P; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Kocaaslan E; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Güren AK; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Arıkan R; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Isık S; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Ercelep O; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Goksu SS; Department of Medical Oncology, Antalya University, Antalya, Turkiye., Alandag C; Department of Medical Oncology, Cumhuriyet University, Sivas, Turkiye., Bilgetekin İ; Dr Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkiye., Caner B; Department of Medical Oncology, Uludag University, Bursa, Turkiye., Sahin AB; Department of Medical Oncology, Uludag University, Bursa, Turkiye., Gulmez A; Faculty of Medicine, Department of Medical Oncology, Inonu University, Malatya, Turkey., Akagunduz B; Clinic of Medical Oncology, Mengucekgazi Training and Research Hospital, Erzincan, Turkiye., Kose F; Department of Medical Oncology, Baskent University, Adana, Turkiye., Kaplan MA; Department of Medical Oncology, Dicle University, Diyarbakir, Turkiye., Dogan E; Department of Medical Oncology, Erciyes University, Kayseri, Turkiye., Sakalar T; Department of Medical Oncology, Erciyes University, Kayseri, Turkiye., Guven DC; Department of Medical Oncology, Hacettepe University, Ankara, Turkiye., Gurbuz M; Department of Medical Oncology, Ankara University, Ankara, Turkiye., Ergun Y; Department of Medical Oncology, Ankara Numune Training and Research Hospital, Ankara, Turkiye., Karaagac M; Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkiye., Turker S; Clinic of Medical Oncology, Ankara Dışkapı Yıldırım Beyazıt Research and Training Hospital, Ankara, Turkiye., Ozkul O; Department of Medical Oncology, Sakarya University, Sakarya, Turkıye., Yıldız B; Department of Medical Oncology, Gülhane Training and Research Hospital, Ankara, Turkey., Sahin S; Department of Medical Oncology, Van Education and Research Hospital, Van, Turkey., Demiray AG; Department of Medical Oncology, Pamukkale University, Denizli, Turkiye., Sari M; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Erdogan B; Department of Medical Oncology, Trakya University, Istanbul, Turkiye., Hacıbekiroglu İ; Department of Medical Oncology, Sakarya University, Sakarya, Turkıye., Çakmak Öksüzoğlu ÖB; Dr Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital, Ankara, Turkiye., Kilickap S; Department of Medical Oncology, Hacettepe University, Ankara, Turkiye., Bilici A; Department of Medical Oncology, Medipol University, Istanbul, Turkiye., Bayoglu İV; Department of Medical Oncology, Marmara University, Istanbul, Turkiye., Topaloglu S; Department of Medical Oncology, Trakya University, Istanbul, Turkiye., Cicin İ; Department of Medical Oncology, Trakya University, Istanbul, Turkiye.

Publikováno v: Journal of chemotherapy (Florence, Italy) [J Chemother] 2024 Nov; Vol. 36 (7), pp. 613-621. Date of Electronic Publication: 2024 Jan 23.

HER2 exon 20 mutant non-small cell lung cancer with complete remission of intracranial metastases with trastuzumab deruxtecan: a case report.

Autor: Güren AK; Division of Medical Oncology, Department of Internal Medicine, Marmara University School of Medicine, Istanbul, Turkey., Kocaaslan E, Ağyol Y, Majidova N, Sever N, Erel P, Çelebi A, Arikan R, Işik S, Sari M, Bayoğlu İV, Köstek O

Publikováno v: Anti-cancer drugs [Anticancer Drugs] 2024 Sep 01; Vol. 35 (8), pp. 769-773. Date of Electronic Publication: 2024 May 16.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The effect of CIS BIPV as a shading device on building life cycle energy performance.

Autor: Göksu, A. Umur¹ (AUTHOR) augoksu@yildiz.edu.tr, Zorer Gedik, Gülay¹ (AUTHOR)

Publikováno v: International Journal of Sustainable Energy. December 2023, Vol. 42 Issue 1, p575-593. 19p.

Integrating self-efficacy in the cyclical process of paediatric asthma management: a new perspective.

Autor: Montalbano, Laura¹ laura.montalbano@irib.cnr.it, Ferrante, Giuliana², Alesi, Marianna³, La Grutta, Stefania¹

Publikováno v: Psychology, Health & Medicine. Jul2023, Vol. 28 Issue 6, p1582-1590. 9p. 1 Diagram, 1 Chart.